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The  functions  of  plexins  and  their  ligands, 
semaphorins, have been extensively studied in 
the central nervous system (CNS). They repre-
sent two large families of molecules that can 
transduce signals essential for the regulation of 
neuronal  repulsion  and  attraction,  cell  shape, 
motility, and cell–cell interactions (Tran et al., 
2007). In addition to their roles in the CNS, the 
diverse functions of plexins and semaphorins 
have also been identified in cardiac develop-
ment (Toyofuku et al., 2004b), vascularization 
and angiogenesis (Gu et al., 2003a), and tumor-
igenesis (Neufeld and Kessler, 2008). More re-
cent  data  strongly  indicate  a  role  for  these 
molecules in the immune system (Suzuki et al., 
2008). For example, plexin-A1 is expressed by 
DCs and regulates DC interaction with T cells 
to affect adaptive immunity (Wong et al., 2003; 
Takegahara et al., 2006). Plexin-C1 is also found 
on DCs, although its role is less defined and 
only mildly affects T cell activation (Walzer et al., 
2005). A more recent paper showed the high 
expression  of  plexin-D1  in  double-positive 
thymocytes and a role for this protein in the 
control of intrathymic migration of these cells 
from cortical to medullary region (Choi et al., 
2008). Therefore, plexins are involved in diverse 
functions in the immune system.
Plexin-A4 belongs to plexin A-type group 
(Tran et al., 2007) and serves as a guidance cue 
molecule in sensory and sympathetic neurons 
(Yaron et al., 2005) and hippocampal mossy   
fibers (Suto et al., 2007). One recent study 
identified plexin-A4 as a negative regulator   
in T  cell  activation  (Yamamoto  et  al.,  2008).   
T cells lacking plexin-A4 (Plxna4/) exhibited 
hyperproliferative  responses  upon  stimula-
tions in vivo and in vitro. However, given the 
much higher expression of plexin-A4 in mye-
loid cells relative to lymphoid cells (Yamamoto 
et al., 2008), the role of plexin-A4 in cells of 
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Plexins and semaphorins are ligand–receptor pairs that serve as guidance molecules in the 
nervous system and play some roles in immunity. Plexins are similar to the Toll-like recep-
tors (TLRs) in their evolutionary conservation from flies to mammals. By studying plexin-
A4–deficient (Plxna4/) innate immune cells, in this study we show a novel influence of 
plexin-A4 on TLR signaling. Plxna4/ cells exhibit defective inflammatory cytokine pro-
duction upon activation by a spectrum of TLR agonists and bacteria. Plexin-A4 is required 
for TLR-induced activation of the small guanosine triphosphate hydrolase (GTPase) Rac1 
(ras-related C3 botulinum toxin substrate 1). Rac1 activation is accompanied by JNK  
(c-Jun N-terminal kinase) and NF-B activation, culminating in TLR-induced binding of  
NF-B and AP-1 to the promoters of inflammatory cytokines. Plxna4/ mice are remark-
ably resistant to TLR agonist–induced inflammation and polymicrobial peritonitis caused by 
cecal ligation and puncture. Administration of a ligand of plexin-A4, Sema3A (semaphorin 
3A), exacerbates the cytokine storm caused by TLR agonists and bacterial sepsis. TLR en-
gagement can induce Sema3A expression, thus completing an autocrine loop. These find-
ings expand the role of plexins to TLR signaling and suggest plexin-A4 and Sema3A as new 
intervention points for treating sepsis.
© 2010 Wen et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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immunofluorescence staining (Fig. 1 B) and flow cytometry 
analysis (Fig. 1 C).
Because of the selective expression of plexin-A4 in my-
eloid cells, we sought to delineate the role of plexin-A4 in 
functions that are well studied in cells of this lineage. Previous 
work has shown that plexin-A1 on DCs mediates the activa-
tion of T cells (Wong et al., 2003; Takegahara et al., 2006).   
In contrast, plexin-A4 is not involved in DC antigen presen-
tation because OVA323–339-specific OTII CD4+ T cell prolif-
eration was comparable when stimulated with either WT or 
Plxna4/ BM-derived DCs (BMDCs) that have been loaded 
with either OVA323–339 peptide or whole OVA protein (Fig. S1). 
Next we evaluated the role of plexin-A4 in type I IFN pro-
duction by pDCs. WT and Plxna4/ pDCs isolated from the 
BM generated comparable amounts of IFN- in response to 
stimulation with TLR7 (R837) or TLR9 (B-type CpG oligo-
deoxynucleotide [CpG-B]) agonists. This indicates that plexin-
A4 does not play a role in the antigen-presenting function of 
mDCs or in type I IFN production by pDCs during TLR 
stimulation (Fig. S2).
Plexin-A4 is required for TNF and IL-6 production  
in macrophages
We next examined the role of plexin-A4 in cytokine produc-
tion in response to TLR activation. Plxna4/ and WT mice 
showed no difference in the percentage or absolute number of 
peritoneal macrophages, as determined by the analysis of a cyto-
spin sample (Fig. S3, A–C). A variety of TLR agonists were 
used to stimulate naive peritoneal macrophages, including 
Pam3Cys (TLR2), polyinosinic-polycytidylic acid (poly(I:C); 
TLR3), LPS (TLR4), R837 (TLR7), and CpG-B (TLR9). 
During  TLR stimulation with these diverse agonists, Plxna4/ 
peritoneal macrophages generated a significantly lower amount 
of TNF and IL-6 mRNA and protein compared with similarly 
treated WT controls (Fig. 1, D and E). In addition to peritoneal 
macrophages, Plxna4/ BM-derived macrophages (BMMs; 
Fig. S4 A) and BMDCs (Fig. S4 B) exhibited defective TNF 
and IL-6 production upon TLR stimulation when compared 
with their WT counterparts. Statistical analyses indicate signif-
icant differences between similarly treated WT and Plxna4/ 
cells. These findings show that plexin-A4 is required for TLR-
initiated proinflammatory cytokines.
We also tested the role of macrophage plexin-A4 in response 
to bacterial challenge. Both Gram-positive (Listeria monocytogenes 
and Staphylococcus aureus) and -negative (Escherichia coli and Salmo-
nella  typhimurium)  bacteria  were  used  to  stimulate  peritoneal 
macrophages. In all cases, bacteria-challenged Plxna4/ macro-
phages produced significantly reduced levels of TNF and IL-6 
mRNA and protein when compared with WT macrophages 
(Fig. 2, A and B). These data suggest that plexin-A4 is important 
in the bacteria-induced, inflammatory cytokine response.
Plexin-A4 mediates the activation of NF-B and JNK but 
not ERK (extracellular signal-regulated kinase) or p38
NF-B and MAPK signaling pathways control the produc-
tion of inflammatory cytokines during macrophage activation 
myeloid lineage such as macrophages and DCs needs to   
be elucidated.
The innate immune system constitutes the first line of   
defense by rapidly detecting invading pathogens and nonmicro-
bial danger signals through the pattern recognition receptors. 
Several classes of pattern recognition receptors have been iden-
tified; the best-characterized are the Toll-like receptors (TLRs; 
Iwasaki and Medzhitov, 2004; Akira et al., 2006). TLR family 
members are localized either on the cell surface (TLR1, TLR2, 
TLR4, TLR5,  and TLR6)  or  in  endosomal  compartments 
(TLR3, TLR7, TLR8, and TLR9) to detect a multitude of 
pathogen-associated molecular patterns. TLR activation leads 
to the direct interactions of the TLR Toll–IL-1 receptor (TIR) 
domain with a cytoplasmic TIR-containing adaptive molecule 
such as MyD88 (myeloid differentiation primary response gene 
88), TIR domain–containing adaptor-inducing IFN- (TRIF), 
TRIF-related adaptor molecule, or TIR domain–containing 
adaptor  protein. Activation  of  MyD88-dependent  signaling 
pathway results in the activation of IL-1 receptor–associated 
kinases, the ubiquitin ligase TRAF6 (TNF receptor–associated 
factor 6), TAK1 (TGF-activated kinase 1) complex, NF-B   
transcription  factor,  and  mitogen-activated  protein  kinases 
(MAPKs). TRIF-dependent type I IFN requires a cascade   
involving the adaptor TRAF3, the kinase TBK1, the IKK- 
(inhibitor of B kinase ), and the transcription factor IRF3 
(IFN-regulatory factor 3; Akira et al., 2006).
In this study, we demonstrate that plexin-A4 in macro-
phages is required for optimal cytokine production upon TLR 
stimulation and bacterial challenge. Plexin-A4 deficiency re-
sulted in compromised activation of NF-B, c-Jun N-terminal 
kinase (JNK), and a small guanosine triphosphate hydrolase 
(GTPase), Rac1 (ras-related C3 botulinum toxin substrate 1). 
The  critical  role  of  plexin-A4  in  innate  inflammatory  re-
sponses was confirmed in models of septic shock and polymi-
crobial peritonitis. Sema3A (semaphorin 3A) serves as a ligand 
for plexin-A4 and enhances LPS-induced macrophage activa-
tion and cytokine production in a plexin-A4–dependent 
manner. This study extends the role of plexins as regulators of 
the TLR pathway.
RESULTS
Plexin-A4 is expressed by myeloid and monocytic cells
Plexin-A4  is  highly  expressed  in  the  nervous  system  and 
functions as an axon guidance factor during neuronal devel-
opment (Yaron et al., 2005; Suto et al., 2007). To investigate 
the role of plexin-A4 in the immune system, we analyzed the 
Plxna4 messenger RNA (mRNA) expression level in differ-
ent immune subpopulations. Cells of the lymphoid lineage 
(T, B, and NK cells) showed no detectable expression, whereas 
cells of the myeloid lineage, including macrophages and my-
eloid DCs (mDCs), expressed relatively high levels of the 
gene with the exception of plasmacytoid DCs (pDCs), which 
expressed a low level of the gene (Fig. 1 A). The highest level 
of Plxna4 mRNA was observed in peritoneal macrophages. 
Plexin-A4 protein was detected on the surface of WT but 
not of Plxna4/ peritoneal macrophages, as determined by JEM VOL. 207, December 20, 2010 
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macrophages showed an abrogation of   
p65 phosphorylation and significantly re-
duced JNK phosphorylation but no change 
in  ERK1/2  and  p38  phosphorylation   
(Fig. 3 A). In accordance with defective 
p65 phosphorylation during LPS stimula-
tion, Plxna4/ macrophages showed a 
defect in IB phosphorylation compared 
with WT macrophages (Fig. 3 A). As speci-
ficity  controls,  Plxna4/  macrophages 
were not defective in response to TNF, 
anti-CD40,  and  IFN-  treatment. The 
phosphorylation of MAPKs upon TNF   
or anti-CD40 treatment (Fig. 3 B) and of 
STAT1 (signal transducer activators of 
transcription 1) upon IFN- treatment 
(Fig. 3 C) was not altered in Plxna4/ 
macrophages. This indicates that plexin- 
A4  specifically  mediates TLR  activation. 
Additionally, Plxna4/ peritoneal macro-
phages showed no defect in Akt phosphory-
lation in response to TLR activation by 
Pam3Cys and LPS stimulation (Fig. 3 D). These findings indi-
cate that plexin-A4 deficiency leads to a TLR-specific defect in 
NF-B and JNK activation. Furthermore, this defect is not 
caused by decreased TLR expression because the mRNA levels 
of Tlr2, Tlr3, Tlr4, Tlr7, or Tlr9 were similar between WT and 
Plxna4/ peritoneal macrophages (Fig. S5). The primer sets 
used in the RT-PCR analyses are described in Table S2.
in  response  to TLR  agonists  and  microbial  pathogens   
(Vallabhapurapu and Karin, 2009). The defective production of 
TNF and IL-6 by Plxna4/ macrophages prompted us to in-
vestigate the function of plexin-A4 in these signaling pathways. 
After LPS stimulation, naive WT peritoneal macrophages   
exhibited  enhanced  phosphorylation  of  p65,  JNK,  p38,   
and  ERK1/2  MAPKs  as  expected.  In  contrast,  Plxna4/  
Figure 1.  Plexin-A4 is required for TNF and 
IL-6 production in macrophages. (A) Expression 
of Plxna4 mRNA in different immune subpopula-
tions was normalized to Actb mRNA level. T cells, 
B cells, NK cells, BM pDCs, and splenic mDCs were 
isolated by FACS sorting. BMMs and BMDCs were, 
respectively, cultured from BM cells in the pres-
ence of L929 cell supernatant and GM-CSF plus 
IL-4. Macrophages were isolated by adherence for 
2 h at 37°C. Results are expressed as mean ± SD. 
(B) Immunofluorescence staining of plexin-A4 
and F4/80 in WT and Plxna4/ peritoneal macro-
phages. (C) WT and Plxna4/ peritoneal macro-
phages were stained with IgG control (gray fill) or 
antibody against mouse plexin-A4 (black lines). 
Histograms show gated CD11b+ cells. The data 
shown in A–C are representative of two indepen-
dent experiments. (D and E) Peritoneal macro-
phages were left unstimulated () or were 
stimulated with 5 µg/ml Pam3Cys, 10 µg/ml 
poly(I:C), 1 µg/ml ultrapure LPS, 10 µg/ml R837, 
or 4 µg/ml CpG-B for 4 h. TNF and IL-6 mRNA (D) 
and protein (E) were measured by RT-PCR and 
ELISA, respectively. The results shown in D and E 
are representative of five independent experi-
ments and are expressed as mean ± SD. *, P < 
0.05 compared with WT peritoneal macrophages.2946 Plexin-A4 and semaphorin 3A drive TLR signaling | Wen et al.
Therefore, we examined whether plexin-A4 
regulates  the  activation  of  small  GTPases 
during TLR activation. A small GTPase pull-
down assay was used in which the binding 
domain of the downstream effector of a par-
ticular GTPase was used to pull down the 
GTP-bound and thus activated form of that 
GTPase.  LPS-stimulated WT  macrophages 
displayed an increase in the GTP-bound 
form of Rac1 and Cdc42 when compared 
with unstimulated controls (Fig. 4 A). LPS-
stimulated Plxna4/ macrophages exhibited 
a dramatic reduction in the quantity of GTP-
bound Rac1 when compared with WT cells, 
whereas GTP-bound Cdc42 and RhoA were 
indistinguishable. Thus,  plexin-A4  affects  the  activation  of 
Rac1, which is known to promote NF-B activation and cyto-
kine production in TLR-stimulated macrophages (Arbibe et al., 
2000; Sanlioglu et al., 2001). In support of the importance of 
Rac1 in TLR-stimulated gene expression, a specific Rac1 inhib-
itor, NSC23766 (Gao et al., 2004), was used and found to sig-
nificantly attenuate TNF and IL-6 production in WT peritoneal 
macrophages stimulated by various TLR agonists (Fig. 4 B). 
However, NSC23766 showed no inhibitory effect on cytokine 
production by TLR-activated Plxna4/ macrophages. This is 
compatible with the conclusion that Rac1 activation is signif-
icantly attenuated in Plxna4/ macrophages such that a Rac1 
inhibitor has no further suppressive effect on these cells.
Plxna4/ mice exhibit reduced cytokine storm and are 
protected from lethal challenge with LPS and poly(I:C)
We next evaluated the physiological relevance of these find-
ings. We first determined the number of immune cells in the 
Plxna4/ mice. No apparent defect was detected for all im-
mune cell types tested, including mDCs, pDCs, neutrophils, 
monocytes, macrophages, CD4+ or CD8+ T cells, B cells, and 
NK cells (Fig. S6 and Table S1). Thus, any physiological differ-
ence observed between WT and Plxna4/ mice is not caused 
by a change in immune subpopulations.
Because Plxna4/ macrophages showed decreased TNF 
and IL-6 production during TLR stimulation in vitro, we 
sought to determine the in vivo role of plexin-A4. Mice   
were injected intraperitoneally with either LPS (12.5 mg/kg 
We next tested whether impaired NF-B and JNK activa-
tion in Plxna4/ macrophages causes defective binding of the 
downstream transcription factors, p65 and c-Jun, to the pro-
moter regions of Tnfa and Il6. Chromatin immunoprecipita-
tion (ChIP) assays were performed by using specific anti-p65 
and anti-phospho–c-Jun antibodies. Appropriate primer sets 
were designed that flanked the well-defined binding sites of 
B and c-Jun at the promoter regions of Tnfa and Il6 (Galvez 
et al., 2009; Leng et al., 2009). 1 h after stimulation with poly 
(I:C) or LPS (Fig. 3 E) or Pam3Cys or CpG (Fig. 3 F), WT 
macrophages showed enhanced binding of p65 and c-Jun at 
both Tnfa and Il6 promoters, which correlated with the in-
creased expression of these inflammatory genes. Conversely, 
Plxna4/ macrophages showed significantly less p65 and   
c-Jun binding at these promoters compared with similarly 
treated WT controls. These data show that plexin-A4 mediates 
TLR-induced NF-B and JNK activation to cause the chro-
mosomal activation of cytokine promoters.
Plexin-A4 causes the activation of the small GTPase Rac1 
but not RhoA and Cdc42
Several  members  of  the  plexin  family  such  as  plexin-B1 
(Swiercz et al., 2002) and plexin-A1 (Turner et al., 2004) me-
diate their downstream effects through the activation of the 
Rho family of small GTPases such as RhoA, Rac1, and Cdc42. 
More importantly, Rac1 serves an essential role in NF-B ac-
tivation and cytokine production in response to either TLR2 
(Arbibe et al., 2000) or TLR4 (Sanlioglu et al., 2001) agonists. 
Figure 2.  Plexin-A4 is required for cytokine 
production in response to bacterial challenge. 
Peritoneal macrophages isolated from WT or 
Plxna4/ mice were left unstimulated () or were 
stimulated with E. coli, S. typhimurium, L. monocyto-
genes, or S. aureus at an MOI of 40. (A and B) TNF 
and IL-6 mRNA (A) and protein (B) were measured by 
RT-PCR and ELISA, respectively. The results shown are 
representative of three independent experiments and 
are expressed as mean ± SD. *, P < 0.05 compared 
with WT peritoneal macrophages.JEM VOL. 207, December 20, 2010 
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Figure 3.  Plexin-A4 is required for LPS-induced activation of NF-B and JNK but does not affect TNF, CD40, or PI3K–Akt signaling pathways. 
Peritoneal macrophages were isolated from WT and Plxna4/ mice by peritoneal lavage. (A) Immunoblot analysis of NF-B and MAPK signaling molecules 
was performed with WT and Plxna4/ macrophages left untreated (0) or treated for 15, 30, or 60 min with 1 µg/ml ultrapure LPS. Densitometric analysis was 
performed to quantify the immunoblots based on three independent experiments (bar graphs). Results are expressed as mean ± SD. *, P < 0.05 compared with 
WT macrophages. (B) Macrophages were treated with 20 ng/ml recombinant mouse TNF or with 5 µg/ml anti-CD40 after 1 ng/ml TNF priming for 3 h. TNF 
priming is required to up-regulate CD40 expression (Lich et al., 2007). Immunoblotting was performed. (C) Macrophages were treated with recombinant 
mouse IFN-, and STAT1 phosphorylation at Tyr701 was detected by immunoblotting. (D) Macrophages were treated with either 5 µg/ml Pam3Cys or 1 µg/ml 
LPS. Akt phosphorylated at Ser473 was detected by immunoblotting. The results shown in B–D are representative of three independent experiments.  
(E and F) ChIP assay of the binding of p65 or c-Jun at the promoter regions of Tnfa and Il6 gene in WT and Plxna4/ peritoneal macrophages left untreated 
() or treated with 10 µg/ml poly(I:C), 1 µg/ml ultrapure LPS, 5 µg/ml Pam3Cys, or 4 µg/ml CpG for 1 h. The results shown in E and F are representative of 
three independent experiments and are expressed as mean ± SD. *, P < 0.05 compared with similarly treated WT peritoneal macrophages.2948 Plexin-A4 and semaphorin 3A drive TLR signaling | Wen et al.
peritonitis model that closely replicates 
the nature and course of clinical sepsis 
(Hubbard  et  al.,  2005). Acute  sepsis   
results in a high mortality rate, which is 
primarily caused by the overzealous pro-
duction of proinflammatory cytokines. 
WT mice with cecal punctures showed 
an 80% mortality rate as early as 3 d after 
CLP  (Fig.  6 A).  However,  Plxna4/ 
mice were significantly protected from CLP-induced lethality in 
sepsis (P = 0.0285). Thus, the absence of plexin-A4 provided a 
clear survival benefit. We also examined inflammatory cytokine 
levels in the peritoneal lavage, serum, and, lung homogenate   
before and after CLP-induced peritonitis. At 4 and 24 h after 
CLP, Plxna4/ mice produced significantly reduced levels of 
inflammatory cytokines such as TNF, IL-1, IL-6, IL-12p70, 
CCL2, and CCL3 in the peritoneal lavage fluid (Fig. 6 B), serum 
(Fig. 6 C), and lung homogenate (Fig. 6 D) compared with WT 
mice. Therefore, plexin-A4 enhances the septic inflammatory re-
sponse and promotes a cytokine storm in a peritonitis model.
Plexin-A4 does not affect macrophage phagocytosis  
and bacteria killing
Another essential factor that contributes to host survival during 
acute sepsis is efficient phagocytosis and killing of invading bac-
teria (Matsukawa et al., 2000). The dramatic survival benefit   
in Plxna4/ mice prompted us to investigate the function of 
plexin-A4 in macrophage phagocytosis and bacteria killing. 24 h 
after CLP surgery, there were similar levels of bacterial loads in 
body weight) or poly(I:C) (20 mg/kg body weight), and the 
peritoneal lavage fluid was analyzed for inflammatory cyto-
kines by the Multi-plex ELISA assay. 4 h after the injection of 
LPS or poly(I:C), both localized (Fig. 5 A) and systemic (Fig. 
5 B) levels of inflammatory cytokines, including TNF, IL-1, 
IL-6,  IL-12p70,  CCL2,  and  CCL3,  were  attenuated  in 
Plxna4/ mice compared with WT mice. The production of 
a plethora of inflammatory cytokines is frequently detrimen-
tal to the animals and referred to as the cytokine storm. We 
next examined morbidity among animals injected with TLR 
agonists. Although WT mice succumbed to high doses of 
TLR agonists, Plxna4/ mice were significantly protected 
from LPS- or poly(I:C)-induced lethality (Fig. 5 C). These 
findings indicate that plexin-A4 enhances the in vivo inflam-
matory responses induced by TLR agonists.
Plxna4/ mice are resistant to septic inflammation induced 
by cecal ligation and puncture (CLP)
To further evaluate the role of plexin-A4 during in vivo bacterial 
infection, we used a well-defined CLP-induced polymicrobial 
Figure 4.  Plexin-A4 is required for LPS-
induced activation of small GTPase Rac1. 
(A) WT and Plxna4/ peritoneal macrophages 
were left untreated (0) or treated for 15 or 30 
min with 1 µg/ml ultrapure LPS. GTP-bound 
Rac1 and Cdc42 were affinity precipitated 
using Rac1/Cdc42-binding domain of PAK 
fused with GST. GTP-bound RhoA was affinity 
precipitated using RhoA-binding domain of 
rhotekin fused with GST. Bound proteins were 
analyzed by immunoblotting. Total Rac1, 
Cdc42, and RhoA in cell lysate were used as 
loading controls. Densitometric analysis was 
performed to quantify the immunoblots based 
on three independent experiments (bar 
graphs). Results are expressed as mean ± SD. 
*, P < 0.05 compared with WT macrophages. 
(B) Peritoneal macrophages isolated from WT 
and Plxna4/ mice were pretreated with or 
without (medium) a Rac1 inhibitor, 200 µM 
NSC23766 for 1 h, followed by stimulation 
with 5 µg/ml Pam3Cys, 10 µg/ml poly(I:C),  
1 µg/ml ultrapure LPS, 10 µg/ml R837, or 4 µg/
ml CpG for 4 h. TNF and IL-6 were measured 
by ELISA. The results shown are representative 
of three independent experiments and are 
expressed as mean ± SD.JEM VOL. 207, December 20, 2010 
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genotypes after the extracellular bacteria were killed by antibiotics 
and the E. coli–loaded macrophages were incubated for different 
time periods (Fig. 7 E).  These data indicate that plexin-A4 does not 
play a role in bacterial phagocytosis and killing in macrophages.
Sema3A enhances LPS-induced cytokine production  
in a plexin-A4–dependent manner
Previous  studies  in  the  CNS  have  identified  Sema3A   
and Sema6A as ligands for plexin-A4 (Yaron et al., 2005;   
the peritoneal lavage, blood, and lung homogenate from WT and 
Plxna4/ mice, indicating that plexin-A4 is not required for 
bacterial clearance (Fig. 7 A). WT and Plxna4/ peritoneal 
macrophages also did not differ in the in vitro phagocytosis of 
GFP-expressing E. coli at different time points (Fig. 7, B and C) 
or multiplicities of infection (MOIs; 10 or 100; Fig. 7 D). Fur-
thermore, there was no difference in the bacterial killing capacity 
of WT and Plxna4/ peritoneal macrophages, as similar num-
bers of E. coli were recovered from macrophages of both   
Figure 5.  Plxna4/ mice are protected from septic shock induced by poly(I:C) or LPS. (A and B) Inflammatory cytokines in peritoneal lavage (A) 
and serum (B) 4 h after the administration of poly(I:C) (20 mg/kg body weight), LPS (12.5 mg/kg body weight), or PBS control (n = 4 per group per experi-
ment) were measured by ELISA. The results are expressed as mean ± SD. *, P < 0.05 compared with WT mice. (C) Survival of WT and Plxna4/ mice (n = 8 
per group per experiment) given intraperitoneal injection of poly(I:C) (left) or LPS (right). The results shown in A–C are representative of two experiments.2950 Plexin-A4 and semaphorin 3A drive TLR signaling | Wen et al.JEM VOL. 207, December 20, 2010 
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Suto et al., 2007). To assess whether these two molecules are 
plexin-A4 ligands in the immune system, we first analyzed 
Sema3a and Sema6a mRNA expression levels in immune sub-
populations (Fig. S7). The highest level of Sema3a mRNA was 
observed in cells of the lymphoid lineage such as T, B, and NK 
cells. Myeloid and monocytic cells also expressed Sema3a but 
at a lower level. Sema6a mRNA was expressed at a relatively 
low level in all immune subpopulations that we analyzed. The 
level of Sema6a was nearly 100× lower than that of Sema3a 
when normalized to the Actb signal.
Figs. 1, 3, and 4 show that optimal LPS-stimulated cyto-
kine production in macrophages requires intact plexin-A4 
expression. One possible explanation for this observation   
is  that  LPS  promotes  the  production  and/or  secretion  of 
Sema3A and/or Sema6A in macrophages, which then engage 
plexin-A4  to  activate  macrophages 
through an autocrine loop. To exam-
ine this possibility, peritoneal macro-
phages were treated with either LPS 
(Fig. 8 A) or other TLR agonists, in-
cluding  Pam3Cys,  poly(I:C),  R837, 
and CpG-B (Fig. S8). All TLR ago-
nists resulted in significantly elevated Sema3a but not Sema6a 
mRNA levels. Furthermore, immunoblot analysis of the super-
natant after 2 or 4 h of LPS treatment showed the induced 
appearance of proteolytic-processed Sema3A (65 kD; Fig. 8 B), 
as observed by others (Adams et al., 1997; Catalano et al., 
2006; Lepelletier et al., 2006). This suggests that TLR stimula-
tion of macrophages can induce Sema3A expression, which 
might engage plexin-A4 in a signaling loop that amplifies in-
flammatory signals and promotes cytokine production.
To functionally assess whether Sema3A or Sema6A serves 
as a ligand for plexin-A4 in macrophages, WT or Plxna4/ 
peritoneal macrophages were stimulated with increasing con-
centrations of Sema3A or Sema6A in the absence or presence 
of LPS. These ligands were expressed as chimeric proteins 
consisting of the human IgG1 Fc fragment fused to either 
Figure 6.  Plxna4/ mice are protected from polymicrobial peritonitis induced by CLP. (A) Survival of WT and Plxna4/ mice (n = 10 per group 
per experiment) after CLP or sham procedure. The results shown in A are representative of three individual experiments. (B–D) Inflammatory cytokines in 
peritoneal lavage (B), serum (C), and lung homogenate (D) before or 4, 24, or 72 h after CLP (n = 5 per group per experiment) were measured by ELISA. 
The results shown in B–D are representative of at least two individual experiments and are expressed as mean ± SD. *, P < 0.05 compared with cytokine 
levels in peritoneal lavage, serum, or lung homogenate from WT mice.
 
Figure 7.  Plexin-A4 is not required for 
macrophage phagocytosis and bacteria 
killing. (A) WT and Plxna4/ mice were sub-
jected to CLP surgery. Bacterial loads in peri-
toneal lavage (left), blood (middle), and lung 
homogenate (right) were determined by 
counting the CFU. Data represent five mice 
per group with duplicate measurements per 
mouse. Horizontal black lines represent group 
mean values. (B) FACS histograms showing 
phagocytosis of E. coli–GFP (MOI = 100) by 
WT (black lines) or Plxna4/ (gray fill) perito-
neal macrophages at 37°C. (C and D) Mean 
fluorescence intensities (MFIs) of GFP showing 
phagocytosis of E. coli–GFP after various time 
periods (C) or at different MOIs (D) by WT and 
Plxna4/ peritoneal macrophages at 37°C. 
(E) WT and Plxna4/ peritoneal macrophages 
were treated with E. coli (strain LF82) at an 
MOI of 10 (left) or 100 (right) for 1 h at 37°C, 
followed by the addition of 100 µg/ml genta-
micin. Intracellular alive bacteria were deter-
mined by plate counting after various time 
periods (0, 1, 2, or 3 h). The data shown in A–E 
are representative of two independent experi-
ments, and results in D and E are expressed  
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mice (Fig. 8 F). Collectively, these in vitro and in vivo results 
suggest that plexin-A4 binding by Sema3A synergizes with 
TLR engagement by its agonists to amplify innate inflamma-
tory responses. Strategies to reduce Sema3A engagement of 
plexin-A4 should be beneficial in controlling an adverse inflam-
matory response associated with endotoxin shock or sepsis.
DISCUSSION
The multimember TLR family was first discovered in Drosoph-
ila melanogaster and shown to play an important role in host de-
fense to fungal pathogens (Lemaitre et al., 1996). Since then, it 
is widely recognized that members of this large family are key 
regulators  and  receptors  that  recognize  pathogen  products 
ranging from peptides, sugars, and lipids to nucleic acid moi-
eties to initiate innate immunity and inflammatory responses. 
In parallel, the plexin family was initially discovered as impor-
tant guidance molecules in the invertebrate CNS but now has 
expanded its impact to the vasculature, cardiac development, 
angiogenesis, cancer growth, and immunity (Gu et al., 2003a; 
Toyofuku et al., 2004b; Neufeld and Kessler, 2008; Suzuki et al., 
2008).  In  the  immune  system,  several  plexin  members  are 
found to be involved in cell–cell interaction. For example, 
plexin-A1 on DCs significantly affects the ability of DCs to 
activate T lymphocytes (Wong et al., 2003; Takegahara et al., 
2006), whereas plexin-C1 on DCs has a slight effect in the 
same pathway (Walzer et al., 2005). Plexin-B1 on T cells inter-
acts with CD100 expressed by B cells, causing B cell activation 
(Granziero et al., 2003). However, none of the plexin mole-
cules have been shown to regulate TLR signaling. We now 
show the novel intersection of the plexin-A4 and TLR path-
ways through the intracellular activation of Rac1, JNK, and 
NF-B. This intersection results in chromosomal changes at 
the promoters of proinflammatory genes, followed by a pan-
cytokine inflammatory response in response to TLR stimula-
tion and bacterial challenge. It cumulates in a cytokine storm 
that precipitates endotoxin shock induced by TLR agonists 
and sepsis induced by bacterial infection. Furthermore, the 
plexin-A4 ligand Sema3A together with endotoxin can syner-
gistically  induce  cytokine  production  in  a  plexin-A4–  and 
MyD88-dependent manner. Finally, TLR engagement can in-
duce Sema3A expression, thus completing an autocrine loop. 
Collectively, these data reveal a pivotal role of plexin-A4 in 
TLR-induced macrophage cytokine production through acti-
vation of Rac-1, NF-B, and JNK. This study significantly ex-
pands  the  repertoire  of  functions  mediated  by  plexins  to 
include TLR activation.
Plexin’s engagement can result in strong signal transduction 
within the cells (Tran et al., 2007). The cytoplasmic domains of 
plexins have two highly conserved regions that share homology 
with GTPase-activating proteins that are known to stimulate 
the intrinsic GTPase activities of G proteins and thus regulate 
the Ras superfamily of small GTPases. This structural similarity 
suggests that plexins might signal through the Ras family of 
GTPases. Indeed, plexin-B1 exhibits GTPase-activating protein 
activity for R-Ras, which is essential for Sema4D-mediated   
repulsive axon guidance signaling (Oinuma et al., 2004).   
Sema3A or Sema6A. The IgG1 Fc fragment alone was used as 
a negative control. Neither Sema3A nor Sema6A alone in-
duced TNF and IL-6 production in macrophages. In the pres-
ence of a suboptimal concentration of LPS (50 ng/ml), both 
Tnfa and Il6 mRNA were elevated (Fig. 8 C). The addition of 
soluble Sema3A (Fig. 8 C, left, open bars) enhanced LPS- 
induced Tnfa and Il6 mRNA in WT peritoneal macrophages in 
a dose-dependent manner. In contrast, Sema6A (Fig. 8 C, right, 
open bars) or IgG Fc control had no effect. This enhancement 
of LPS-responsiveness was absent in Plxna4/ macrophages 
(Fig. 8 C, closed bars). A similar pattern was detected for TNF 
and IL-6 proteins (Fig. 8 D). The absence of a functional effect of 
Sema6A agrees with its low expression in different immune 
populations (Fig. S7, right) and the failure of LPS to induce 
its expression (Fig. 8 A). These data indicate that Sema3A en-
gagement enhances cytokine production by macrophages but 
only when LPS is present. This suggests the possibility that 
both LPS and Sema3A are required for optimal intracellular 
signaling and eventual cytokine production in macrophages.
To delineate the separate contribution of LPS and Sema3A 
to macrophage signaling, we tested the responses of WT, 
Plxna4/, and Myd88/ macrophages to LPS alone, Sema3A 
alone, or LPS + Sema3A. MyD88 was used as a surrogate for 
TLR because it is the common adaptor of multiple TLRs.   
We used Rac1 activation as a measurement of macrophage acti-
vation because it represents a proximal response in the plexin 
pathway and it is also required during TLR activation. WT 
macrophages stimulated by LPS or Sema3A alone showed ele-
vated GTP-bound Rac1 when compared with unstimulated 
cells, whereas the two stimuli together caused the highest level 
of activated Rac1 (Fig. 8 E). In contrast, Plxna4/ macro-
phages stimulated by LPS or Sema3A did not exhibit elevated 
GTP-Rac1 levels. This suggests that plexin-A4 is not only re-
quired for signals that emanate from the binding of Sema3A 
but also required for LPS engagement of TLR. Similarly, nei-
ther  Sema3A  nor  LPS  increased  GTP-Rac1  in  Myd88/ 
macrophages. These findings indicate that the dual engagement 
of TLR and plexin-A4 by their respective ligands is required 
for optimal macrophage signaling. In composite, these data re-
veal a complex interplay between TLR and plexin-A4 signal-
ing. LPS engagement of TLR induces Sema3A expression to 
cause autocrine activation of plexin-A4. However, LPS activa-
tion also requires the engagement of plexin-A4 by Sema3A for 
optimal intracellular signaling and vice versa.
The aforementioned experiments were performed in cell 
culture with highly enriched macrophage preparations; thus, 
it was important to assess the physiological relevance of these 
findings. To address this, we assessed whether Sema3A en-
gagement of plexin-A4 could synergistically exacerbate CLP-
induced septic inflammation. A single peritoneal injection of 
Sema3A or control IgG Fc at a dosage of 25 µg/kg body 
weight was administrated to WT and Plxna4/ mice 1 h before 
CLP  procedure. We  measured  cytokine  production  in  the 
peritoneal lavage 4 h after CLP. Sema3A-pretreated mice had 
significantly  higher  levels  of  inflammatory  cytokines  than 
IgG Fc–treated controls in WT mice but not in Plxna4/ JEM VOL. 207, December 20, 2010 
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Figure 8.  Sema3A enhances LPS-induced cytokine production in a plexin-A4–dependent manner. (A and B) WT peritoneal macrophages were 
left unstimulated () or were stimulated with 1 µg/ml LPS for 2 or 4 h. Sema3a and Sema6a mRNA (A) and Sema3A protein (B) were analyzed by RT-PCR 
and immunoblotting, respectively. *, P < 0.05 compared with unstimulated macrophages. (C and D) WT and Plxna4/ peritoneal macrophages were stim-
ulated or not with 50 ng/ml LPS for 4 h in the absence or presence of either Sema3A-Fc or Sema6A-Fc fusion proteins (20 or 100 ng/ml). TNF and IL-6 
mRNA (C) and protein (D) were measured by RT-PCR and ELISA, respectively. 100 ng/ml of the IgG Fc fragment was used as negative control. *, P < 0.05 
compared with unstimulated macrophages. (E) Peritoneal macrophages isolated from WT, Plxna4/, and Myd88/ mice were stimulated with 1 µg/ml 
LPS alone, 100 ng/ml Sema3A-Fc alone, or both LPS and Sema3A-Fc for 30 min. Rac1 pull-down assay was performed. Total Rac1 in cell lysate was used 
as control. Densitometric analysis was performed to quantify the immunoblots based on two independent experiments (bar graphs). *, P < 0.05 compared 
with similarly treated WT macrophages. (F) WT and Plxna4/ mice (n = 4 per group per experiment) were pretreated with either Sema3A-Fc or IgG Fc 
control proteins at a dosage of 25 µg/kg body weight 1 h before CLP procedure. Inflammatory cytokines in peritoneal lavage collected 4 h after CLP were 
determined by ELISA. *, P < 0.05 compared with peritoneal lavage from WT mice pretreated with Sema3A-Fc. The results shown in A–F are representative 
of two independent experiments and are expressed as mean ± SD.2954 Plexin-A4 and semaphorin 3A drive TLR signaling | Wen et al.
In addition, the Rho family of small GTPases, which is a sub-
group of Ras superfamily, has been tightly linked to plexin- 
mediated signaling (Tran et al., 2007). Plexin-A1 interacts with 
and depends on Rac1 for its activity in the nervous system 
(Turner et al., 2004). Plexin-B1 activates RhoA and medi-
ates Sema4D-induced axonal growth cone collapse (Swiercz 
et al., 2002). Therefore, the Rho family of small GTPases plays 
an important role in plexin-mediated signal transduction.
The Rho family of small GTPases has also been linked to 
many aspects of the immune system, including hematopoietic 
stem cell regulation (Gu et al., 2003b) and B cell development 
and signaling (Walmsley et al., 2003), as well as DC-induced   
T cell activation (Benvenuti et al., 2004). Importantly, Rac1, a 
well-studied member of the Rho subfamily, has been linked to 
NF-B activation and cytokine production in response to   
either TLR2 (Arbibe et al., 2000) or TLR4 (Sanlioglu et al., 
2001) agonists. The finding that plexins can cause the activation 
of Rho GTPases prompted us to investigate whether plexin-
A4  imposed  its  effects  on  NF-B  activation  through  Rho   
GTPases. TLR  stimulation  can  cause  an  increase  in  GTP-
bound (activated) Rac1 and Cdc42 in macrophages, which is 
then necessary for the activation of NF-B and the production 
of downstream cytokines. Our results show that plexin-A4 de-
ficiency abolished LPS-induced Rac1 activation, whereas 
Cdc42 activation was left intact. Thus, Rac1 serves as a signal 
transducer downstream of plexin-A4 and modulates NF-B 
and JNK activation in macrophages through TLRs. The role of 
Rac in TLR activation was verified by the use of a pharmaco-
logic Rac1 inhibitor that dampened TLR-induced TNF and 
IL-6 production in macrophages.
Whereas it is generally believed that TLR engagement by 
TLR agonists is able to fully activate immune cells, our study 
identifies another requirement during this process involving 
the engagement of membrane plexin-A4 by Sema3A. During 
TLR activation, plexin-A4 binds to its soluble ligand, Sema3A, 
which triggers Rac1, leading to the activation of NF-B and 
JNK. In the absence of TLR stimulation, plexin-A4 activation 
by Sema3A failed to induce cytokine production, indicating 
that plexin-A4–mediated signal is not sufficient for the in-
duction of cytokine production. In the absence of plexin-A4, 
TLR signaling is significantly attenuated but not abolished, 
indicating that TLR signaling is amplified by plexin-A4 acti-
vation but is not initiated by this activation.
A previous study has shown an inhibitory role of plexin-
A4 in mouse T cell activation (Yamamoto et al., 2008), and 
Sema3A has been reported to suppress human T cell prolifer-
ation  (Lepelletier  et  al.,  2006). The  opposite  roles  of  the 
Sema3A–plexin-A4 signaling axis in innate versus adaptive 
immune response mimic other signaling systems such as 
TRAF3, which serves as an inhibitor in lymphocytes but an 
activator in macrophages (He et al., 2007). Our findings show 
that although plexin-A4 is most highly expressed by mono-
cytic and myeloid cell lineages and significantly reduced on 
lymphoid cells, Sema3A is highly expressed by lymphoid cells 
with reduced expression by myeloid/monocytic cell types. 
Thus, it is possible that during an early inflammatory response, 
the smaller amount of Sema3A produced by myeloid and 
monocytic cells together with TLR ligands is sufficient to ac-
tivate the higher density of plexin-A4 on macrophage mem-
brane. Later when T cells are recruited, the higher amounts of 
Sema3A expressed by activated T cells then serve as a feed-
back loop to down-regulate T cell functions, which express 
less plexin-A4 receptors. In addition to these issues, neuropi-
lin, the ligand-binding subunit of Sema3A receptor complex 
in the cardiovascular and nervous system (Gu et al., 2003a), 
may also participate in Sema3A–plexin-A4–mediated immune 
functions. Future investigation is required to assess its role in 
Sema3A-mediated  suppression  and  activation  of T  cells   
and macrophages, respectively.
Our finding shows that Sema6A does not affect inflamma-
tory cytokine production in macrophages. There are several 
ways to explain why a bona fide ligand such as Sema6A en-
gages plexin-A4 in the nervous system but not macrophages. 
First, plexins identified in one cell type/organ do not always 
functionally interact with the same semaphorins in different 
cells/tissues. For example, Sema3A interacts with plexin-A1 in 
the nervous system but with Sema6D during cardiac morpho-
genesis (Toyofuku et al., 2004a). Second, immunostimulation 
may only induce the expression of some semaphorins but not 
others. Our data show that LPS induces the production of 
Sema3A but not Sema6A by macrophages. The induced 
Sema3A synthesis by macrophages can act in an autocrine 
fashion via plexin-A4 to promote inflammatory cytokine pro-
duction. Third, different semaphorins mediate different immu-
nological functions. Our findings suggest that Sema3A but not 
Sema6A promotes LPS-induced cytokine production by mac-
rophages  in  a  plexin-A4–dependent  manner.  However,  we 
cannot rule out the possibility that Sema6A may be required 
for other immune functions such as cell migration that depend 
on plexin-A4. For example, the binding of DC-derived plexin-
A1 and T cell–derived Sema6D is important during DC- 
stimulated T cell activation (Takegahara et al., 2006; O’Connor   
et al., 2008), whereas plexin-A1–dependent entry of DCs into 
lymphatics depends on Sema3A but not Sema6D (Takamatsu 
et al., 2010). Finally, plexin may form a signaling complex with 
other molecules such as neuropilin or DAP12 to mediate di-
vergent semaphorin-initiated signal transduction.
In summary, the biological function of plexin-A4 in the 
activation of a pan-cytokine response has broad clinical im-
plications. New antiinflammatory therapeutic methods are 
needed in the treatment of immune-related diseases such as 
sepsis, rheumatoid arthritis, inflammatory bowel disease, and 
systemic lupus erythematosus. The hallmark of sepsis in the 
acute phase is an exacerbated production of proinflammatory 
cytokines and chemokines, leading to the cytokine storm.   
Although these inflammatory mediators are essential in provid-
ing an immediate host defense, their overzealous production 
can be deleterious to the host if left uncontrolled. Considering 
that sepsis is a leading cause of death worldwide that has little 
effective treatment, there is an urgent need for new therapies 
targeting this disease. Our study suggests a critical role of plexin-
A4 in mediating the production of proinflammatory cytokines, JEM VOL. 207, December 20, 2010 
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ELISA. Cytokines generated by in vitro cultured peritoneal macrophages 
were quantified using the ELISA set for mouse TNF or IL-6 (BD) and mouse 
IFN- ELISA kit (PBL InterferonSource). For the in vivo experiments, con-
centrations of TNF, IL-1, IL-6, IL-12p70, CCL2, and CCL3 were measured 
in cell-free peritoneal lavage fluid, serum, and lung homogenate using a cus-
tomized mouse cytokine 6-plex panel (BioLegend) and a Luminex Bio-Plex 
200 system (Bio-Rad Laboratories).
Immunoblotting. Electrophoresis of proteins was performed by using the 
NuPAGE system (Invitrogen) according to the manufacturer’s protocol. In brief, 
peritoneal macrophages stimulated with LPS or left unstimulated were collected 
and lysed with buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 2 mM EDTA, 
1% Triton X-100, 0.1% SDS, and protease inhibitor cocktail). Proteins were sep-
arated on a NuPAGE gel and were transferred onto nitrocellulose membranes 
(Bio-Rad Laboratories). The membranes were blocked with 10% milk proteins 
in 1× PBS and 0.1% Tween 20 and then probed with the primary antibodies. 
Appropriate horseradish peroxidase–conjugated secondary antibodies were used, 
and  proteins  were  detected  using  the  enhanced  chemiluminescent  reagent 
(Thermo Fisher Scientific).
ChIP assay. Resident peritoneal macrophages were stimulated with various 
TLR agonists for 1 h, and the ChIP assay was performed as described previ-
ously (Wen et al., 2008). Real-time PCR was performed using the primers 
described in Table S3.
Detection of GTP-bound Rac1, Cdc42, and RhoA. The assays for 
GTP-bound Rac1, Cdc42, and RhoA were performed as described previ-
ously (Noren et al., 2000). In brief, peritoneal macrophages were stimulated 
with 1 µg/ml LPS, 100 ng/ml Sema3A-Fc alone, or both. Cells were lysed, 
and GTP-bound Rac1 and Cdc42 were affinity precipitated using Rac1/
Cdc42-binding domain of PAK (PBD) fused with GST. GTP-bound RhoA 
was affinity precipitated using RhoA-binding domain of rhotekin (RBD) 
fused with GST. Bound proteins were resolved on a NuPAGE gel and were 
transferred onto nitrocellulose membranes. Membranes were immunoblotted 
with the appropriate primary antibodies against Rac1, Cdc42, or RhoA.
Experimental sepsis induced by CLP. CLP surgery was performed on 
mice as previously described with minor modifications (Wen et al., 2008).   
In brief, mice were anesthetized with an intraperitoneal injection of 8 mg of 
2,2,2-tribromoethanol (Avertin; Sigma-Aldrich). Under sterile surgical con-
ditions, a 1-cm midline incision was made to the ventral surface of the abdo-
men, and the cecum was exposed. The cecum was partially ligated at its base 
with a 3.0 silk suture and punctured two times with a 21-gauge needle. 
Sham-operated mice were subjected to a similar laparotomy without ligation 
and puncture. Serum and cell-free peritoneal lavage fluid were collected for 
cytokine protein analyses. To determine bacterial loads after CLP surgery, 
peritoneal lavage fluid, EDTA-treated blood, and lung homogenate from   
24 h after CLP were placed on ice and serially diluted in sterile PBS. A 10-µl 
aliquot of each dilution was spread on Luria-Bertani agar plates without   
antibiotics and incubated at 37°C overnight. Colonies were counted and   
expressed as CFU/milliliter. In some experiments, recombinant human 
Sema3A-Fc or human IgG1 Fc control protein was injected intraperitoneally 
at a dosage of 25 µg/kg 1 h before CLP procedure.
Statistical analysis. Statistical analysis was performed with Prism 4 (Graph-
Pad Software, Inc.) for Macintosh. In survival experiments, a log-rank test was 
used to test for significance. For all other experiments, results were presented 
as the mean ± SD, and the unpaired Student’s t test (one tailed) was applied to 
evaluate significance. P-values <0.05 were considered statistically significant.
Online supplemental material. Fig. S1 shows that plexin-A4 does not 
modulate the presentation of OVA antigen by BMDCs. Fig. S2 shows that 
plexin-A4 does not affect TLR-induced IFN- production by pDCs. Fig. S3 
shows that plexin-A4 does not affect the number of peritoneal macrophages. 
Fig. S4 shows that plexin-A4 is required for TLR-induced cytokine production 
which affects host survival in models of sepsis. Therefore, the 
interaction of plexin-A4 and Sema3A presents a new thera-
peutic target for antiinflammatory and antisepsis treatment.
MATERIALS AND METHODS
Mice.  C57BL/6  mice  were  purchased  from  The  Jackson  Laboratory. 
Plxna4/ mice were provided by M. Tessier-Lavigne (Stanford University, 
Stanford, CA; Yaron et al., 2005) and were backcrossed for nine generations 
onto the C57BL/6 background. Myd88/ mice were provided by S. Akira 
(Osaka University, Suita, Osaka, Japan). OTII mice were obtained from   
M. Croft (La Jolla Institute of Allergy and Immunology, La Jolla, CA). Mice were 
treated in accordance with the National Institutes of Health Guide for the 
Care and Use of Laboratory Animals. The Institutional Animal Care and Use 
Committee of the University of North Carolina at Chapel Hill approved all 
experimental procedures.
Reagents.  Pam3Cys,  poly(I:C),  ultrapure  LPS,  imiquimod  (R837),  and 
mouse CpG-B (ODN 1826) were purchased from InvivoGen. LPS (E. coli 
0111:B4) used for in vivo injections was purchased from Sigma-Aldrich.   
Recombinant human Sema3A-Fc, human Sema6A-Fc, and human IgG1 Fc 
were purchased from R&D Systems. The Rac1 inhibitor NSC23766 was ob-
tained from EMD. In immunoblotting experiments, the primary antibodies 
specific for NF-B p65, NF-B p65 phosphorylated at Ser536 (93H1), IB 
phosphorylated  at  Ser32  (14D4),  phospho-ERK1/2  (Thr202/Thr204; 
197G2),  phospho-JNK1/2  (Thr183/Tyr185;  81E11),  and  phospho-p38 
(Thr180/Tyr182) were obtained from Cell Signaling Technology. The pri-
mary antibodies specific for -actin (C-11 horseradish peroxidase), Rac1 
(C-14), Cdc42 (B-8), and RhoA (26C4) were purchased from Santa Cruz 
Biotechnology, Inc. Antibody specific for mouse plexin-A4 has been previ-
ously described (Suto et al., 2007) and was provided by F. Suto (Tohoku Uni-
versity, Aoba-ku, Sendai, Japan). In ChIP analysis, the antibodies specific for 
NF-B p65 (A) X and c-Jun phosphorylated at Ser63 were purchased from 
Santa Cruz Biotechnology, Inc. and Cell Signaling Technology, respectively. 
In assays for GTP-bound Rac1, Cdc42, and RhoA, glutathione-Sepharose 
beads conjugated with either GST-Pak1 PBD (for GTP-bound Rac1 and 
Cdc42) or GST-rhotekin RBD (for GTP-bound RhoA) were provided by 
K. Burridge and L. Sharek of K. Burridge’s laboratory (University of North 
Carolina at Chapel Hill, Chapel Hill, NC).
Peritoneal macrophage isolation and in vitro stimulation. Total peri-
toneal cells were harvested from the peritoneal cavities of naive WT or 
Plxna4/ mice with two 10-ml cold sterile PBS washes. Lavage was pooled 
from mice in the same group. RBCs were lysed in ammonium chloride buffer 
(150 mM NH4Cl, 10 mM NaHCO3, and 1 mM EDTA-tetrasodium). Cyto-
spins were prepared and stained with Diff-Quik solutions, and the number of 
peritoneal macrophages was determined and cultured in RPMI 1640 supple-
mented with 10% FCS, 2 mM l-Gln, 100 U/ml penicillin, and 100 µg strep-
tomycin. Macrophages were plated in 96-well cell culture plate (2 × 105/well) 
and incubated for 2 h at 37°C. Nonadherent cells were removed, and adherent 
cells were washed with complete RPMI 1640 medium, followed by stimula-
tion with various reagents. In some experiments, cells were pretreated with 
200 µM NSC23766 for 1 h, followed by stimulation with TLR agonists.
Bacterial  infection  in  vitro. L. monocytogenes (43251) and S. typhimurium 
(14028) were obtained from the American Type Culture Collection. E. coli strain 
LF82 was provided by R. Balfour Sartor (University of North Carolina at Chapel 
Hill). S. aureus strain RN6390 has been previously described (Labandeira-Rey   
et al., 2007) and was provided by M. Gabriela Bowden (Texas A&M University, 
College Station, TX). All bacterial strains were grown to the late exponential 
phase. The number of viable bacteria used in each experiment was calibrated by 
colony counting. Bacteria were added to peritoneal macrophages at an MOI of 
40 for 1 h at 37°C, and then cells were treated with 100 µg/ml gentamicin to   
kill extracellular bacteria and were further incubated for various time periods   
(S. typhimurium for 1 h; L. monocytogenes, E. coli, and S. aureus for 3 h).2956 Plexin-A4 and semaphorin 3A drive TLR signaling | Wen et al.
He, J.Q., G. Oganesyan, S.K. Saha, B. Zarnegar, and G. Cheng. 2007. TRAF3 
and its biological function. Adv. Exp. Med. Biol. 597:48–59. doi:10 
.1007/978-0-387-70630-6_4
Hubbard, W.J., M. Choudhry, M.G. Schwacha, J.D. Kerby, L.W. Rue III, 
K.I. Bland, and I.H. Chaudry. 2005. Cecal ligation and puncture. Shock. 
24:52–57. doi:10.1097/01.shk.0000191414.94461.7e
Iwasaki, A., and R. Medzhitov. 2004. Toll-like receptor control of the adaptive 
immune responses. Nat. Immunol. 5:987–995. doi:10.1038/ni1112
Labandeira-Rey, M., F. Couzon, S. Boisset, E.L. Brown, M. Bes, Y. Benito, 
E.M. Barbu, V. Vazquez, M. Höök, J. Etienne, et al. 2007. Staphylococcus 
aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science.   
315:1130–1133. doi:10.1126/science.1137165
Lemaitre, B., E. Nicolas, L. Michaut, J.M. Reichhart, and J.A. Hoffmann. 
1996. The dorsoventral regulatory gene cassette spätzle/Toll/cactus con-
trols the potent antifungal response in Drosophila adults. Cell. 86:973– 
983. doi:10.1016/S0092-8674(00)80172-5
Leng, J., B.A. Butcher, C.E. Egan, D.S. Abdallah, and E.Y. Denkers. 2009. 
Toxoplasma gondii prevents chromatin remodeling initiated by TLR-
triggered macrophage activation. J. Immunol. 182:489–497.
Lepelletier, Y., I.C. Moura, R. Hadj-Slimane, A. Renand, S. Fiorentino, C. 
Baude, A. Shirvan, A. Barzilai, and O. Hermine. 2006. Immunosuppressive 
role of semaphorin-3A on T cell proliferation is mediated by inhibi-
tion of actin cytoskeleton reorganization. Eur. J. Immunol. 36:1782– 
1793. doi:10.1002/eji.200535601
Lich, J.D., K.L. Williams, C.B. Moore, J.C. Arthur, B.K. Davis, D.J. Taxman, 
and J.P. Ting. 2007. Monarch-1 suppresses non-canonical NF-kappaB acti-
vation and p52-dependent chemokine expression in monocytes. J. Immunol. 
178:1256–1260.
Matsukawa,  A.,  C.M.  Hogaboam,  N.W.  Lukacs,  P.M.  Lincoln,  H.L. 
Evanoff, and S.L. Kunkel. 2000. Pivotal role of the CC chemokine, 
macrophage-derived  chemokine,  in  the  innate  immune  response.  
J. Immunol. 164:5362–5368.
Neufeld, G., and O. Kessler. 2008. The semaphorins: versatile regulators of 
tumour progression and tumour angiogenesis. Nat. Rev. Cancer. 8:632–
645. doi:10.1038/nrc2404
Noren, N.K., B.P. Liu, K. Burridge, and B. Kreft. 2000. p120 catenin 
regulates the actin cytoskeleton via Rho family GTPases. J. Cell Biol. 
150:567–580. doi:10.1083/jcb.150.3.567
O’Connor, B.P., S.Y. Eun, Z. Ye, A.L. Zozulya, J.D. Lich, C.B. Moore, H.A. 
Iocca, K.E. Roney, E.K. Holl, Q.P. Wu, et al. 2008. Semaphorin 6D regu-
lates the late phase of CD4+ T cell primary immune responses. Proc. Natl. 
Acad. Sci. USA. 105:13015–13020. doi:10.1073/pnas.0803386105
Oinuma, I., Y. Ishikawa, H. Katoh, and M. Negishi. 2004. The Semaphorin 
4D receptor Plexin-B1 is a GTPase activating protein for R-Ras. Science. 
305:862–865. doi:10.1126/science.1097545
Sanlioglu, S., C.M. Williams, L. Samavati, N.S. Butler, G. Wang, P.B. 
McCray  Jr.,  T.C.  Ritchie,  G.W.  Hunninghake,  E.  Zandi,  and  J.F. 
Engelhardt. 2001. Lipopolysaccharide induces Rac1-dependent reac-
tive oxygen species formation and coordinates tumor necrosis factor-
alpha secretion through IKK regulation of NF-kappa B. J. Biol. Chem. 
276:30188–30198. doi:10.1074/jbc.M102061200
Suto, F., M. Tsuboi, H. Kamiya, H. Mizuno, Y. Kiyama, S. Komai, M. 
Shimizu,  M.  Sanbo,  T.  Yagi,  Y.  Hiromi,  et  al.  2007.  Interactions 
between plexin-A2, plexin-A4, and semaphorin 6A control lamina- 
restricted projection of hippocampal mossy fibers. Neuron. 53:535–547. 
doi:10.1016/j.neuron.2007.01.028
Suzuki, K., A. Kumanogoh, and H. Kikutani. 2008. Semaphorins and their 
receptors in immune cell interactions. Nat. Immunol. 9:17–23. doi:10 
.1038/ni1553
Swiercz, J.M., R. Kuner, J. Behrens, and S. Offermanns. 2002. Plexin-B1 directly 
interacts with PDZ-RhoGEF/LARG to regulate RhoA and growth cone 
morphology. Neuron. 35:51–63. doi:10.1016/S0896-6273(02)00750-X
Takamatsu, H., N. Takegahara, Y. Nakagawa, M. Tomura, M. Taniguchi, 
R.H.  Friedel,  H.  Rayburn,  M.  Tessier-Lavigne,  Y.  Yoshida,  T. 
Okuno, et al. 2010. Semaphorins guide the entry of dendritic cells into 
the  lymphatics  by  activating  myosin  II.  Nat.  Immunol.  11:594–600. 
doi:10.1038/ni.1885
Takegahara, N., H. Takamatsu, T. Toyofuku, T. Tsujimura, T. Okuno, K.  
Yukawa, M. Mizui, M. Yamamoto, D.V. Prasad, K. Suzuki, et al. 2006.   
in BMMs and BMDCs. Fig. S5 shows that plexin-A4 does not affect TLR 
mRNA expression in peritoneal macrophages. Fig. S6 shows that plexin-A4 
does not affect immune cell composition in the spleen. Fig. S7 shows the 
expression of Sema3a and Sema6a mRNA in different immune cells. Fig. S8   
shows that TLR agonists induce an increase in Sema3a mRNA level in peri-
toneal macrophages. Table S1 shows the quantification of different immune 
cell populations in the spleens from seven WT and six Plxna4/ naive mice. 
Table S2 shows the sequences of RT-PCR primers. Table S3 shows the se-
quences of primers for the ChIP assay. Online supplemental material is avail-
able at http://www.jem.org/cgi/content/full/jem.20101138/DC1.
We thank Drs. Marc Tessier-Lavigne, Shizuo Akira, and Michael Croft for the  
supply of mutant mice and Fumikazu Suto for the mouse plexin-A4 antibody.  
We also thank Drs. Keith Burridge and Lisa Sharek for the provision of reagents  
and protocols for the GTP-bound Rac1, Cdc42, and RhoA pull-down assay.
This work was supported by National Institutes of Health grants (R37-
AI029564 to J.P.-Y. Ting and HL-080166 to K. Burridge). H. Wen is a recipient of the 
Postdoctoral Fellowship of the American Heart Association (Mid-Atlantic Affiliate) 
and Postdoctoral Fellowship of Cancer Research Institute.
The authors have declared that no conflict of interest exists.
Submitted: 8 June 2010
Accepted: 26 October 2010
REFERENCES
Adams, R.H., M. Lohrum, A. Klostermann, H. Betz, and A.W. Püschel. 
1997. The chemorepulsive activity of secreted semaphorins is regulated 
by furin-dependent proteolytic processing. EMBO J. 16:6077–6086. 
doi:10.1093/emboj/16.20.6077
Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and 
innate immunity. Cell. 124:783–801. doi:10.1016/j.cell.2006.02.015
Arbibe, L., J.P. Mira, N. Teusch, L. Kline, M. Guha, N. Mackman, P.J. 
Godowski, R.J. Ulevitch, and U.G. Knaus. 2000. Toll-like receptor 2-
mediated NF-kappa B activation requires a Rac1-dependent pathway. 
Nat. Immunol. 1:533–540. doi:10.1038/82797
Benvenuti, F., S. Hugues, M. Walmsley, S. Ruf, L. Fetler, M. Popoff, 
V.L. Tybulewicz, and S. Amigorena. 2004. Requirement of Rac1 and 
Rac2 expression by mature dendritic cells for T cell priming. Science. 
305:1150–1153. doi:10.1126/science.1099159
Catalano, A., P. Caprari, S. Moretti, M. Faronato, L. Tamagnone, and A. 
Procopio. 2006. Semaphorin-3A is expressed by tumor cells and alters 
T-cell signal transduction and function. Blood. 107:3321–3329. doi:10 
.1182/blood-2005-06-2445
Choi, Y.I., J.S. Duke-Cohan, W.B. Ahmed, M.A. Handley, F. Mann, J.A. 
Epstein, L.K. Clayton, and E.L. Reinherz. 2008. PlexinD1 glycoprotein 
controls migration of positively selected thymocytes into the medulla. 
Immunity. 29:888–898. doi:10.1016/j.immuni.2008.10.008
Galvez, A.S., A. Duran, J.F. Linares, P. Pathrose, E.A. Castilla, S. Abu-Baker, 
M. Leitges, M.T. Diaz-Meco, and J. Moscat. 2009. Protein kinase Czeta 
represses the interleukin-6 promoter and impairs tumorigenesis in vivo. 
Mol. Cell. Biol. 29:104–115. doi:10.1128/MCB.01294-08
Gao, Y., J.B. Dickerson, F. Guo, J. Zheng, and Y. Zheng. 2004. Rational 
design and characterization of a Rac GTPase-specific small molecule 
inhibitor.  Proc.  Natl.  Acad.  Sci.  USA.  101:7618–7623.  doi:10.1073/ 
pnas.0307512101
Granziero, L., P. Circosta, C. Scielzo, E. Frisaldi, S. Stella, M. Geuna, S. 
Giordano, P. Ghia, and F. Caligaris-Cappio. 2003. CD100/Plexin-B1   
interactions sustain proliferation and survival of normal and leukemic 
CD5+  B  lymphocytes.  Blood.  101:1962–1969.  doi:10.1182/blood- 
2002-05-1339
Gu, C., E.R. Rodriguez, D.V. Reimert, T. Shu, B. Fritzsch, L.J. Richards, 
A.L. Kolodkin, and D.D. Ginty. 2003a. Neuropilin-1 conveys sema-
phorin and VEGF signaling during neural and cardiovascular develop-
ment. Dev. Cell. 5:45–57. doi:10.1016/S1534-5807(03)00169-2
Gu,  Y.,  M.D.  Filippi,  J.A.  Cancelas,  J.E.  Siefring,  E.P.  Williams,  A.C. 
Jasti, C.E. Harris, A.W. Lee, R. Prabhakar, S.J. Atkinson, et al. 2003b. 
Hematopoietic cell regulation by Rac1 and Rac2 guanosine triphospha-
tases. Science. 302:445–449. doi:10.1126/science.1088485JEM VOL. 207, December 20, 2010 
Article
2957
Plexin-A1  and  its  interaction  with  DAP12  in  immune  responses   
and  bone  homeostasis.  Nat.  Cell  Biol.  8:615–622.  doi:10.1038/ 
ncb1416
Toyofuku,  T.,  H.  Zhang,  A.  Kumanogoh,  N.  Takegahara,  F.  Suto,  J. 
Kamei, K. Aoki, M. Yabuki, M. Hori, H. Fujisawa, and H. Kikutani. 
2004a. Dual roles of Sema6D in cardiac morphogenesis through region-
specific association of its receptor, Plexin-A1, with off-track and vascu-
lar endothelial growth factor receptor type 2. Genes Dev. 18:435–447. 
doi:10.1101/gad.1167304
Toyofuku, T., H. Zhang, A. Kumanogoh, N. Takegahara, M. Yabuki, K. 
Harada, M. Hori, and H. Kikutani. 2004b. Guidance of myocardial pat-
terning in cardiac development by Sema6D reverse signalling. Nat. Cell 
Biol. 6:1204–1211. doi:10.1038/ncb1193
Tran, T.S., A.L. Kolodkin, and R. Bharadwaj. 2007. Semaphorin regula-
tion of cellular morphology. Annu. Rev. Cell Dev. Biol. 23:263–292. 
doi:10.1146/annurev.cellbio.22.010605.093554
Turner, L.J., S. Nicholls, and A. Hall. 2004. The activity of the plexin-
A1  receptor  is  regulated  by  Rac.  J.  Biol.  Chem.  279:33199–33205. 
doi:10.1074/jbc.M402943200
Vallabhapurapu, S., and M. Karin. 2009. Regulation and function of NF-
kappaB transcription factors in the immune system. Annu. Rev. Immunol. 
27:693–733. doi:10.1146/annurev.immunol.021908.132641
Walmsley, M.J., S.K. Ooi, L.F. Reynolds, S.H. Smith, S. Ruf, A. Mathiot, 
L. Vanes, D.A. Williams, M.P. Cancro, and V.L. Tybulewicz. 2003. 
Critical roles for Rac1 and Rac2 GTPases in B cell development and 
signaling. Science. 302:459–462. doi:10.1126/science.1089709
Walzer, T., L. Galibert, and T. De Smedt. 2005. Dendritic cell function in mice   
lacking Plexin C1. Int. Immunol. 17:943–950. doi:10.1093/intimm/dxh274
Wen, H., Y. Dou, C.M. Hogaboam, and S.L. Kunkel. 2008. Epigenetic 
regulation of dendritic cell-derived interleukin-12 facilitates immuno-
suppression after a severe innate immune response. Blood. 111:1797–
1804. doi:10.1182/blood-2007-08-106443
Wong, A.W., W.J. Brickey, D.J. Taxman, H.W. van Deventer, W. Reed, 
J.X. Gao, P. Zheng, Y. Liu, P. Li, J.S. Blum, et al. 2003. CIITA- 
regulated  plexin-A1  affects  T-cell-dendritic  cell  interactions.  Nat. 
Immunol. 4:891–898. doi:10.1038/ni960
Yamamoto,  M.,  K.  Suzuki,  T.  Okuno,  T.  Ogata,  N.  Takegahara,  H. 
Takamatsu, M. Mizui, M. Taniguchi, A. Chédotal, F. Suto, et al. 2008. 
Plexin-A4 negatively regulates T lymphocyte responses. Int. Immunol. 
20:413–420. doi:10.1093/intimm/dxn006
Yaron,  A.,  P.H.  Huang,  H.J.  Cheng,  and  M.  Tessier-Lavigne.  2005. 
Differential requirement for Plexin-A3 and -A4 in mediating responses 
of sensory and sympathetic neurons to distinct class 3 Semaphorins. 
Neuron. 45:513–523. doi:10.1016/j.neuron.2005.01.013